Maxim Yankelevich

580 total citations
20 papers, 192 citations indexed

About

Maxim Yankelevich is a scholar working on Oncology, Hematology and Neurology. According to data from OpenAlex, Maxim Yankelevich has authored 20 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Hematology and 6 papers in Neurology. Recurrent topics in Maxim Yankelevich's work include Neutropenia and Cancer Infections (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Neuroblastoma Research and Treatments (5 papers). Maxim Yankelevich is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Neuroblastoma Research and Treatments (5 papers). Maxim Yankelevich collaborates with scholars based in United States, Russia and Canada. Maxim Yankelevich's co-authors include Lawrence G. Lum, Archana Thakur, Steven Buck, Sri Vidya Kondadasula, Nai‐Kong V. Cheung, Margaret A. Goodell, Joseph Kaplan, Jonathan L. Finlay, Wafik Zaky and Vedat Yildiz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neuro-Oncology.

In The Last Decade

Maxim Yankelevich

19 papers receiving 188 citations

Peers

Maxim Yankelevich
A. Audemard France
Aysche Landmann Germany
Renee H. Grau United States
Sara Pérez‐Jaume Spain
Cyrus Khan United States
Nicholas Coupe United Kingdom
Harry Miao United States
Seongmin Choi South Korea
Jasmin Lisfeld Germany
Heidrun Mitzel-Rink Germany
A. Audemard France
Maxim Yankelevich
Citations per year, relative to Maxim Yankelevich Maxim Yankelevich (= 1×) peers A. Audemard

Countries citing papers authored by Maxim Yankelevich

Since Specialization
Citations

This map shows the geographic impact of Maxim Yankelevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Yankelevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Yankelevich more than expected).

Fields of papers citing papers by Maxim Yankelevich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Yankelevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Yankelevich. The network helps show where Maxim Yankelevich may publish in the future.

Co-authorship network of co-authors of Maxim Yankelevich

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Yankelevich. A scholar is included among the top collaborators of Maxim Yankelevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Yankelevich. Maxim Yankelevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yankelevich, Maxim, Archana Thakur, Shakeel Modak, et al.. (2024). Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells. Journal for ImmunoTherapy of Cancer. 12(3). e008744–e008744. 12 indexed citations
2.
Yankelevich, Maxim, Wafik Zaky, Lucie Lafay‐Cousin, et al.. (2024). Marrow-ablative consolidation chemotherapy and molecular targeted therapy delivered in a risk-adapted manner for newly diagnosed children with choroid plexus carcinoma: A work in progress. Neuro-Oncology Advances. 6(1). vdae109–vdae109. 1 indexed citations
3.
Yankelevich, Maxim, Jonathan L. Finlay, William J. Kupsky, et al.. (2021). Molecular insights into malignant progression of atypical choroid plexus papilloma. Molecular Case Studies. 7(1). a005272–a005272. 6 indexed citations
4.
Yankelevich, Maxim, et al.. (2020). Patterns and correlates of preserved humoral immunity to vaccines in children following allogeneic hematopoietic stem cell transplantation. Pediatric Transplantation. 25(5). e13936–e13936. 2 indexed citations
5.
Yankelevich, Maxim, Jonathan L. Finlay, William J. Kupsky, et al.. (2020). RARE-51. MOLECULAR INSIGHTS INTO MALIGNANT PROGRESSION OF CHOROID PLEXUS PAPILLOMA (CPP). Neuro-Oncology. 22(Supplement_3). iii453–iii453. 1 indexed citations
6.
7.
Marupudi, Neena I., et al.. (2019). Pneumocephalus in a Pediatric Patient with Glioma Receiving Trametinib. Pediatric Neurosurgery. 55(1). 51–53. 1 indexed citations
8.
Rayner, P H, et al.. (2019). Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children. Journal of Pediatric Hematology/Oncology. 41(6). e395–e401. 2 indexed citations
9.
Yankelevich, Maxim, Shakeel Modak, Roland Chu, et al.. (2019). Phase I study of OKT3 x hu3F8 bispecific antibody (GD2Bi) armed T cells (GD2BATs) in GD2-positive tumors.. Journal of Clinical Oncology. 37(15_suppl). 2533–2533. 13 indexed citations
10.
Yankelevich, Maxim, et al.. (2017). Small Split Doses of CD34 + Peripheral Blood Stem Cells to Support Repeated Cycles of Nonmyeloablative Chemotherapy. Case Reports in Oncological Medicine. 2017(1). 4184879–4184879.
11.
Zaky, Wafik, Girish Dhall, Soumen Khatua, et al.. (2015). Choroid plexus carcinoma in children: The Head Start experience. Pediatric Blood & Cancer. 62(5). 784–789. 40 indexed citations
12.
Mallhi, Kanwaldeep, Lawrence G. Lum, Kirk R. Schultz, & Maxim Yankelevich. (2014). Hematopoietic Cell Transplantation and Cellular Therapeutics in the Treatment of Childhood Malignancies. Pediatric Clinics of North America. 62(1). 257–273. 5 indexed citations
13.
Doganis, Dimitrios, Basim I. Asmar, Maxim Yankelevich, Ronald Thomas, & Yaddanapudi Ravindranath. (2013). How Many Sources Should Be Cultured for the Diagnosis of a Blood Stream Infection in Children with Cancer?. Pediatric Hematology and Oncology. 30(5). 416–424. 6 indexed citations
14.
Doganis, Dimitrios, Basim I. Asmar, Maxim Yankelevich, Ronald Thomas, & Yaddanapudi Ravindranath. (2013). Predictive Factors for Blood Stream Infections in Children with Cancer. Pediatric Hematology and Oncology. 30(5). 403–415. 10 indexed citations
15.
Yankelevich, Maxim, Sri Vidya Kondadasula, Archana Thakur, et al.. (2012). Anti‐CD3 × anti‐GD2 bispecific antibody redirects T‐cell cytolytic activity to neuroblastoma targets. Pediatric Blood & Cancer. 59(7). 1198–1205. 61 indexed citations
16.
Yankelevich, Maxim, Margaret A. Goodell, & Joseph Kaplan. (2007). Efficacy of delayed administration of post-chemotherapy granulocyte colony-stimulating factor: evidence from murine studies of bone marrow cell kinetics. Experimental Hematology. 36(1). 9–16. 19 indexed citations
17.
Yankelevich, Maxim, et al.. (2006). The role of cytotoxic T cell antigen-2 (CTLA2) in mouse hematopoietic stem cell (HSC) transplant engraftment and reconstitution examined by lentiviral vector transduction. Biology of Blood and Marrow Transplantation. 12(2). 133–133. 2 indexed citations
18.
Yankelevich, Maxim, Judith Margolin, & Margaret A. Goodell. (2005). Expression of Runx1 Isoforms in Sub-Populations of Human Blood and Bone Marrow Cells.. Blood. 106(11). 4244–4244. 1 indexed citations
19.
20.
Yankelevich, Maxim, et al.. (1999). FEASIBILITY AND SAFETY OF PERIPHERAL BLOOD STEM CELL COLLECTION IN CHILDREN WITH POOR-PROGNOSIS SOLID TUMORS: A Single Center Experience. Pediatric Hematology and Oncology. 16(4). 291–298. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Audemard Breakdown of academic impact, for papers by Aysche Landmann Breakdown of academic impact, for papers by Renee H. Grau Breakdown of academic impact, for papers by Sara Pérez‐Jaume Breakdown of academic impact, for papers by Cyrus Khan Breakdown of academic impact, for papers by Nicholas Coupe Breakdown of academic impact, for papers by Harry Miao Breakdown of academic impact, for papers by Seongmin Choi Breakdown of academic impact, for papers by Jasmin Lisfeld Breakdown of academic impact, for papers by Heidrun Mitzel-Rink
Rankless by CCL
2026